We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgeon Volume Impacts Mortality in Aneurysm Repair

By HospiMedica International staff writers
Posted on 09 Mar 2011
A new study reveals that for open repair of intact elective abdominal aortic aneurysms (AAAs), surgeon annual volume rather than institutional volume is more strongly associated with decreased in-hospital mortality.

Researchers at the University of Massachusetts Medical School (Worcester, USA) reviewed the US Nationwide Inpatient Sample (2003-2007) to identify all patients who underwent open repair (5,972 patients) or endovascular aneurysm repair (EVAR, 1,821 patients) for nonruptured AAAs, in 11 participating US states that record a unique physician identifier for each procedure. More...
Surgeon and institution volume were defined as low, medium, and high; stratification by institution volume and then by surgeon volume was performed to analyze the relative effects of both procedures' in-hospital mortality.

The researchers found a significant mortality reduction was associated with both annual institution volume and surgeon volume; high surgeon volume conferred a greater mortality reduction than did high institution volume. When low and medium volume institutions were stratified by surgeon volume, mortality after open AAA repair was inversely proportional to surgeon volume (8.7%, 3.6%, and 0% for low-, medium-, and high-volume surgeons at low-volume institutions, respectively; and 6.7%, 4.8%, and 3.3% for low-, medium-, and high-volume surgeons at medium-volume institutions). High-volume institutions stratified by surgeon volume demonstrated the same trend; however, this finding was not statistically significant. The study was published in the March 2011 issue of the Journal of Vascular Surgery.

"We believe that it is a shortcoming of publicly reported data and volume-based studies to consider EVAR and open AAA repair together, as it can be misleading,” said study coauthor Andres Schanzer, MD, a surgeon at the division of vascular and endovascular surgery. "For example, from an open surgical perspective, it is inappropriate to categorize a center as a high volume AAA institution based on the fact that they perform 50 EVAR's per year and 5 open AAA repairs per year. The reverse also is true, from an EVAR perspective, at a center that performs 50 open AAA repairs per year and 5 EVARs per year.”

According to the researchers, an important finding of the study is that the data indicated that elective EVAR of intact AAAs show universally low mortality rates (2%), regardless of surgeon or hospital experience.

Related Links:

University of Massachusetts Medical School





Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.